Home › Stocks › AMRX › All Fund Holders
AMRX — AMNEAL PHARMACEUTICALS INC · All Fund Holders
Funds holding (latest): 42 · Reported value held: $1.24B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 26.56M | $459.79M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 17.91M | $225.64M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 5.14M | $88.98M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 4.11M | $71.14M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 3.50M | $60.62M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.01M | $52.17M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.15M | $37.17M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.91M | $33.15M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 1.15M | $19.87M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 1.02M | $17.57M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 991.82K | $17.17M | 0.01% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 825.12K | $14.28M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 795.00K | $13.85M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 795.54K | $13.77M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 795.03K | $13.76M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 774.05K | $13.40M | 0.01% | Reduce |
| PSP Investments history | Q2 2026 | 591.84K | $10.24M | 0.03% | Reduce |
| UBS Group AG history | Q2 2026 | 444.40K | $7.69M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 434.13K | $7.51M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 422.39K | $7.31M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 398.19K | $6.89M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 395.64K | $6.85M | 0.00% | Add |
| Arrowstreet Capital history | Q2 2026 | 334.76K | $5.79M | 0.00% | Reduce |
| Prudential Financial history | Q2 2026 | 331.17K | $5.73M | 0.01% | Reduce |
| Two Sigma Investments history | Q2 2026 | 233.27K | $4.04M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2026 | 219.40K | $3.80M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 215.04K | $3.72M | 0.00% | Add |
| Deutsche Bank AG history | Q2 2026 | 171.49K | $2.97M | 0.00% | Add |
| Marshall Wace history | Q3 2021 | 472.14K | $2.52M | 0.01% | New |
| Manulife Financial history | Q2 2026 | 100.83K | $1.75M | 0.00% | Add |
| MFS Investment Management history | Q1 2026 | 127.09K | $1.58M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 87.49K | $1.51M | 0.00% | Reduce |
| Point72 Asset Management history | Q1 2026 | 78.11K | $970.85K | 0.00% | New |
| Wellington Management Group history | Q2 2026 | 55.77K | $965.41K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2026 | 76.22K | $946.98K | 0.00% | Hold |
| Lazard Asset Management history | Q2 2026 | 43.32K | $749.80K | 0.00% | Reduce |
| Amundi US history | Q2 2026 | 39.89K | $690.50K | 0.00% | New |
| CPP Investments history | Q1 2026 | 35.40K | $440.02K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 14.76K | $255.51K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 2.02K | $34.91K | 0.00% | Add |
| Baillie Gifford & Co history | Q1 2022 | 853 | $4.00K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 231.00K | $4.00K | 0.00% | Add |